Melanocytic lesions, spitz tumors, and Don Ferrante's logic [2]

American Journal of Dermatopathology

Volumn 29, Issue 5, 2007, Pages 491-494

  Urso, Carmelo ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; DENDRITIC CELL; DISEASE COURSE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HISTOLOGY; HUMAN; JUVENILE MELANOMA; LETTER; MELANOCYTE; METASTASIS; PRIORITY JOURNAL; SKIN TUMOR;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MELANOMA; MUTATION; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS;

EID: 34648824372     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318146225f     Document Type: Letter

References (52)

1. Manzoni A. I Promessi Sposi. La Nuova Italia Ed., Firenze; 1975:693-696.
2. Mones JM, Ackerman AB. "Atypical" Spitz's nevus, "Malignant" Spitz's nevus, and "Metastasizing" Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol. 2004;26:310-333.
3. Mones JM, Ackerman AB. "Atypical" blue nevus, "malignant" blue nevus, and "metastasizing" blue nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol. 2004;26:407-430.
4. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83:1128-1135.
5. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75:478-494.
6. Busam KJ, Iversen K, Coplan KC, et al. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol. 2001;25:197-204.
7. Xu X, Chu AY, Pasha TL, et al. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol. 2002;26:82-87.
8. Davison JM, Rosenbaum E, Barrett TL, et al. Absence of V599E BRAF mutations in desmoplastic melanomas. Cancer. 2005;103:788-792.
9. Borek BT, McKee PH, Freeman JA, et al. Primary malignant melanoma with rhabdoid features: a histologic and immunocytochemical study of three cases. Am J Dermatopathol. 1998;20:123-127.
10. Abott JJ, Amirkhan RH, Hoang MP. Malignant melanoma with a rhabdoid phenotype. Histologic, immunohistochemical, and ultrastructural study of a case and review of the literature. Arch Pathol Lab Med. 2004;128;686-688.
11. Connelly J, Smith JL. Malignant blue nevus. Cancer. 1991;67:2653-2657.
12. Granter SR, McKee PH, Calonje E, et al. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus. A clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus.' Am J Surg Pathol. 2001;25:316-323.
13. Kao GF, Graham JH, Helwig EB. Cutaneous malignant blue melanoma. Lab Invest. 1981;44:33A.
14. Ariyanayagam-Baksh SM, Baksh SK, Finkelstein SD, et al. Malignant blue nevus. A case report and molecular analysis. Am J Dermatopathol. 2003;25:21-27.
15. Barnhill RL. Malignant melanoma. In Barnhill RL, Piepkorn M, Busam KL, eds. Pathology of melanocytic nevi and malignant melanoma. 2ed. New York: Springer-Verlag; 2004:313-319.
16. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
17. Demunter A, Stas M, Degreef H, et al. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol. 2001;117:1483-1489.
18. Gill M, Cohen J, Renwick N, et al. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Cancer. 2004;101:2636-2640.
19. Lee DA, Cohen JA, Twaddell WS, et al. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer. 2006;106:907-913.
20. Takata M. Goto Y, Nami I, et al. Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas. J Invest Dermatol. 2005;125:318-322.
21. van Elsas A, Zerp SF, van der Flier S, et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol. 1996;149:883-893.
22. Jiveskog S, Ragnarsson-Olding B, Platz A, et al. N-Ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol. 1998;111:757-761.
23. Maldonado JL, Fridlyand J, Patel H, et al: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95:1878-1890.
24. Edwards RH, Ward MR, Wu H, et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet. 2004;41:270-272.
25. Wong CW, Fan YS, Chan TL, et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol. 2005;58:640-644.
26. Curtin JA, Fiedlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Eng J Med. 2005;353:2135-2147.
27. Ackerman AB. Malignant melanoma: a unifying concept. Hum Pathol. 1980;11:591-595.
28. Ackerman AB, David KM. A unifying concept of malignant melanoma: Biologic aspects. Hum Pathol. 1986;17:438-440.
29. Busam KJ, Barnhill RL. Dermal melanocytoses, blue nevi, and related conditions. In Barnhill RL, Piepkorn M, Busam KL, eds. Pathology of melanocytic nevi and malignant melanoma. 2ed. New York: Springer-Verlag; 2004:199-222.
30. Gill M, Celebi JT. B-RAF and melanocytic neoplasia. J Am Acad Dermatol. 2005;53:108-114.
31. McWhorter HE, Woolner LB. Pigmented nevi, juvenile melanomas, and malignant melanomas in children. Cancer. 1954:7:564-585.
32. Sprecher E, Bergman R, Meilick A, et al. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. J Cutan Pathol. 1999;26:72-77.
33. Ribé A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol. 2003;16:505-511.
34. Kapur P, Selim MA, Roy LC, et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol. 2005;18:197-204.
35. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol. 2003;121:1160-1162.
36. Gill M, Renwick N, Silvers DN, et al. Lack of BRAF mutations in Spitz nevi. J Invest Dermatol. 2004;122:1325-1326.
37. Mihic-Probst D, Perren A, Schmid S, et al. Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma. Anticancer Res. 2004;24:2415-2418.
38. Palmedo G, Hantsche M, Rutten A, et al. The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol. 2004;31:266-270.
39. Turner DJ, Zirvi MA, Barany F, et al. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. J Cutan Pathol. 2005;32:334-339.
40. Indsto JO, Kumar S, Wang L. et al. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. J Cutan Pathol. 2007;34:448-455.
41. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutation in nevi. Nat Genet. 2003;33:19-20.
42. Uribe P, Wistuba II, Gonzales S. BRAF mutations: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol. 2003;25:365-370.
43. Ichii-Nakato M, Takata M, Takayanagi S, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126;2111-2118.
44. Brose MS, Volpe P, Feldman M, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002;62:6997-7000.
45. Dong J, Phelps RG, Qiao R, et al. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res. 2003;63:3883-3885.
46. van Dijk MCRF, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N.RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol. 2005;29:1145-1151.
47. Fullen DR, Poynter JN, Lowe L, et al. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol. 2006;19:1324-1332.
48. Urso C. A new perspective for Spitz tumors? Am J Dermatopathol. 2005;27:364-366.
49. Ackerman AB. Garble that derives from lack of definition. Am J Dermatopathol. 2005;27:369-370.
50. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumor: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30:513-520.
51. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic neoplasms between expert pathologists. Hum Pathol. 1996;27:528-531.
52. Cerroni L. Spitzoid tumors. A matter of perspective? Am J Dermatopathol. 2004;26:1-3.